These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 981189

  • 1. [Treatment of obesity with mazindol (author's transl)].
    Escher M.
    Schweiz Rundsch Med Prax; 1976 Jun 15; 65(24):751-4. PubMed ID: 981189
    [No Abstract] [Full Text] [Related]

  • 2. [The clinical evaluation of teronac (Mazindol) in the treatment of children with obesity. Part I. Effect of the drug on somatic patterns and exercise capacity (author's transl)].
    Gołebiowska M, Chlebna-Sokoł D, Mastalska A, Zwaigzne-Raczyńska J.
    Przegl Lek; 1981 Jun 15; 38(2):311-4. PubMed ID: 7017826
    [No Abstract] [Full Text] [Related]

  • 3. [Mazindol, an anorectic of a new series, in the treatment of obesity (author's transl)].
    Dolecek R.
    Cas Lek Cesk; 1975 Feb 21; 114(8):249-54. PubMed ID: 1095197
    [No Abstract] [Full Text] [Related]

  • 4. [Mazindol in the treatment of obesity in diabetics (author's transl)].
    Felt V, Nedvídková J.
    Cas Lek Cesk; 1977 Sep 30; 116(39):1214-7. PubMed ID: 922789
    [No Abstract] [Full Text] [Related]

  • 5. [Long-term treatment of patients with obesity using mazindol and a reducing diet].
    van Seters AP, Bouwhuis-Hoogerwerf ML, Goslings BM, van Nieuwkoop L, van Slooten H, Struijk-Wielinga T.
    Ned Tijdschr Geneeskd; 1982 May 29; 126(22):990-4. PubMed ID: 7110390
    [No Abstract] [Full Text] [Related]

  • 6. [Comparative trial on the effects of diet, mazindol, and placebo in the treatment of exogenous obesity (author's transl)].
    Mies R.
    Med Klin; 1976 Nov 12; 71(46):2013-6. PubMed ID: 995040
    [Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of Teronac (mazindol) in the treatment of obesity in children. Part II. Anorectic properties and side effects (author's transl)].
    Gołebiowska M, Chlebna-Sokół D, Kobierska I, Konopińska A, Małek M, Mastalska A, Zwaigzne-Raczyńska J.
    Przegl Lek; 1981 Nov 12; 38(3):355-8. PubMed ID: 7017827
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of obesity with a non-amphetamine anorexigenic agent (author's transl)].
    Riesco J, Troncoso G, Costamaillere L, Rodríguez J.
    Rev Med Chil; 1977 Jun 12; 105(6):375-9. PubMed ID: 331428
    [No Abstract] [Full Text] [Related]

  • 9. AN 448 Sandoz (Mazindol) in the treatment of obesity.
    Wallace AG.
    Med J Aust; 1976 Mar 13; 1(11):343-5. PubMed ID: 775265
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical use of mazindol in the treatment of essential obesity].
    Guazzelli R, Piazzini M, Conti C, Papi L, Strazzulla G, Matassi L.
    Clin Ter; 1987 Mar 15; 120(5):385-91. PubMed ID: 2953538
    [No Abstract] [Full Text] [Related]

  • 12. [Anorexiant drugs in the ambulant treatment of obese patients (author's transl)].
    Jenny S, Zimmermann KG, Radielovic P, Bühlmann AA.
    Schweiz Rundsch Med Prax; 1976 Jul 13; 65(28):874-8. PubMed ID: 1005298
    [No Abstract] [Full Text] [Related]

  • 13. A multi-centre general practice trial of mazindol in the treatment of obesity.
    Maclay WP, Wallace MG.
    Practitioner; 1977 Mar 13; 218(1305):431-4. PubMed ID: 322112
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Results in the treatment of obesity by Mazindol (AN 448 Sandoz) in hospitalized subjects using the method of double-blind trial (author's transl)].
    Kreze A, Velemínsky J, Toman A.
    Bratisl Lek Listy; 1976 May 13; 65(5):537-43. PubMed ID: 788862
    [No Abstract] [Full Text] [Related]

  • 16. [Mazindol (Teronac) in the treatment of predominant by food-dependent obesity].
    Husmann F.
    Med Welt; 1976 Oct 01; 27(40):1904-8. PubMed ID: 790077
    [No Abstract] [Full Text] [Related]

  • 17. [Mazindol (AN 448 Sandoz) in ambulatory treatment of obesity; its effect on body composition and adipose tissue].
    Rath R, Vondra K, Wenkeová J.
    Cesk Gastroenterol Vyz; 1977 Sep 01; 31(6):389-94. PubMed ID: 589677
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of mazindol (teronac) on various hormonal indicators in children with simple obesity].
    Komorowski JM, Zwaigzne-Raczyńska J, Owczarczyk I, Gołebiowska M, Zarzycki J.
    Pediatr Pol; 1982 Apr 01; 57(4):241-6. PubMed ID: 6755371
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.